Revenue Analysis - AXNX
Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.
AXNX Corporation
Annual
Revenue by Product Line
Latest quarterly revenue breakdown by product segments
Quarterly Product Revenue
Product Revenue Details
Detailed breakdown of revenue by product line
Sacral Neuromodulation
0.0% of total revenue
$92.3M
Bulkamid
0.0% of total revenue
$23.8M
Historical Revenue Data
Quarterly product revenue breakdown over time (Last 6 records)
| Date | Bulkamid | Sacral Neuromodulation |
|---|---|---|
| 9/30/2024 | $23.8M | $92.3M |
| 6/30/2024 | $23.4M | $91.2M |
| 3/31/2024 | $19.7M | $71.7M |
| 12/31/2023 | $55.4M | $217.9M |
| 9/30/2023 | $19.2M | $73.9M |
| 6/30/2021 | $5.7M | $40.2M |
Revenue Trend Analysis
Analysis of major growing and declining segments based on recent revenue data
Product Segments
Stable Segments
Sacral Neuromodulation+1.2%
Bulkamid+2.1%
Earnings Reports
Want to see how AXNX's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.
View Earnings Reports